India’s struggle with rising obesity and diabetes is well documented. But a revolution is now underway, one that might reshape how we manage both conditions: the rise of GLP-1-based weight loss drugs.
Dr. Ambrish Mithal, India’s leading endocrinologi…
Side effects to surprises: Dr Ambrish Mithal on India’s weight-loss drug revolution
